In particular, the above-mentioned polymorphisms of the FSHB gene promoter region could become quite effective biomarkers that would make it possible to identify a group of women at higher risk of developing endometriosis, and to carry out measures for reducingthe chances of the disease developing and for its early diagnosis. Here, FSHB is linked to endometriosis.